Of a total population of 305 million Americans, 58% are estimated to experience insomnia symptoms or sleep disorders. Companies across America are trying to sell us a perfect night’s sleep with pills, premium mattresses, high tech pillows, white noise machines, aromatherapy, and more. And it has fast become a $23.7 billion a year industry.
As obesity rates climb and Americans age, more people are developing sleep apnea, restless legs syndrome and other sleep disorders. Plus, stressors from the economy, terrorism and longer workdays is resulting in more sleepless nights. Some claim that “sleep is the new sex—we need more of it and can’t get enough of it.” First launched in 1977, there are now 3,500 to 4,000 “sleep labs” in the United States. These labs perform sleep studies and help design treatment programs for insomniacs and those with sleep apnea and other conditions.
This groundbreaking new Marketdata study examines the “sleep” market and its components, covering markets for: anti-insomnia drugs (over-the-counter & prescription), sleep labs/sleep centers, mattresses and pillows, CPAPs (continuous positive airway pressure devices) for sleep apnea, and retail sleep aids: earplugs, sleep lamps, sound conditioning machines, eye masks, books on sleep). Marketdata also performed primary research -- a custom mail survey of sleep labs in March-May, deriving key operating ratios, average revenues, and much more.
The study includes market size estimates for 1987-2007, with 2008 and 2012 Forecasts, client demographics, in-depth competitor profiles and rankings in each market segment, discussions of market nature & structure, history and evolution, in view of recent Medicare rulings regarding home testing. Advertising strategies, R&D, sleep disorder publicity and other demand factors analyzed.
(0 items)
